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Abstract Metals have been studied as potential chemothera-
peutic agents for cancer therapies due to their high reactivity
toward a wide variety of substances. The characterization of
metal ion-binding capacities is essential to understand the
possible effects of metals on target biomolecules. In the pres-
ent study, biochemical effects of Au(III) and Ga(III) ions on
calf thymus DNA (ctDNA) were studied comparatively via
bioanalytical, spectroscopic, and thermal methods. Briefly,
UV-Vis absorbance spectroscopy, fluorescence spectroscopy,
circular dichroism (CD) spectroscopy, and Fourier transform
infrared (FT-IR) spectroscopy were utilized for spectroscopic
characterization, and isothermal titration calorimetry (ITC)
measurements were performed for thermal analysis. Our re-
sults reveal that both Au(III) and Ga(III) ions are capable of
interacting with ctDNA, and Au(III) ions display a more
favorable interaction and a higher binding affinity. ITC anal-
yses indicate that the Au(III)-DNA interaction displays a
binding affinity (Ka) around 1.43×10
6M−1, while a Ka around
1.17×105 M−1 was observed for the Ga(III)-DNA binding. It
was suggested that both metal ions are unlikely to change the
structural B-conformation while interacting with ctDNA.
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The investigation of novel metal-based anticancer agents has
been a popular field of research since the discovery of the
antitumor activity of cisplatin. While many platinum-based
chemotherapeutic agents have been studied in the last 30 years
[1], a limited spectrum of activity and a number of side effects
associated with these drugs have triggered an increased inter-
est in non-platinum metal-based agents [2, 3]. To this end,
various complexes of gallium, gold, ruthenium, germanium,
cobalt, copper, and zinc have been studied as alternatives to
platinum [3, 4]. After platinum, gallium is the second metal
species that has been approved for use in patients for chemo-
therapeutic purposes, and gallium nitrate has been used for the
treatment of hypercalcemia, lymphoma, and bladder cancer
[5–7]. Ga(III) shares similar chemical properties with Fe(III),
especially with respect to ionic radius, electron affinity, elec-
tronegativity, coordination geometry, and Lewis bases affinity
[3, 6]. Because of these similarities, gallium can participate in
cellular processes and interact with proteins responsible for
iron metabolism [7].
Following cellular uptake, gallium binds to the enzyme
ribonucleotide reductase and inhibits its catalytic activity.
Ribonucleotide reductase, a key enzyme in DNA replication,
catalyzes the reduction of ribonucleotides to deoxyribonucle-
otides and prevents the activation of the proapoptotic factors
Bax and caspase-3, thereby blocking apoptosis [1, 3, 8]. The
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inhibition of ribonucleotide reductase has been considered to
be an effective means to mediate anticancer activity, and the
antiproliferative and antimitotic effects of gallium are primar-
ily based on its ability to interfere with the activity of this
enzyme [1–3].
Au(III) compounds are isoelectronic and isostructural
with Pt(II) complexes, with which they share a square-
planar tetracoordinated geometry [9]. As such, Au(III)
compounds are potential candidates for anticancer eval-
uation and have been studied extensively for this pur-
pose, with recent research focusing primarily on the
remarkable cytotoxic activity displayed by Au(III) com-
plexes [10, 11]. Consequently, a considerable number of
antineoplastic Au(III) complexes have been reported in
the literature [11, 12].
DNA regulates many biochemical processes that oc-
cur in cellular systems and has been established as the
primary target for many antitumor agents [4, 13, 14].
These agents frequently achieve their antitumor activi-
ties by directly interacting with DNA, thus interfering
with the replication process and inhibiting the prolifer-
ation of tumor cells [4]. Therefore, the investigation of
DNA-anticancer drug-binding mechanisms is critical for
both the development of new therapeutic reagents and
the characterization of existing anticancer drugs [14].
In the present study, the interaction of Ga(III) and
Au(III) with calf thymus DNA (ctDNA) has been ex-
amined by UV-Vis absorbance spectroscopy, fluores-
cence spectroscopy, circular dichroism (CD) spectrosco-
py, and Fourier transform infrared (FT-IR) spectroscopy
for spectroscopic characterization and isothermal titra-
tion calorimetry (ITC) for thermal analysis. Overall,
we describe and compare the effects of Au(III) and
Ga(III) bindings on ctDNA by utilizing a wide range
of analytical techniques and believe that our results will
be crucial for future studies involving the antineoplastic
properties of these metals.
Materials and Methods
Materials and Sample Preparation
All chemical reagents were purchased from Sigma-
Aldrich (USA). ctDNA with an initial concentration of
10 mg/ml was purchased from InvitrogenTM (USA).
Gold(III) chloride hydrate, gallium(III) nitrate hydrate,
and ctDNA solutions were prepared in a 10 mM Tris
( t r i s (hydroxymethyl)aminomethane)-HCl buffer
(pH 7.40) to keep the pH of the solutions stable. Stocks
of ctDNA were stored at −20 °C. Fresh ctDNA solu-
tions were prepared prior to each experiment.
UV-Vis Absorbance Spectroscopy
Equal concentrations of ctDNA solutions were prepared at
300 μM. Different concentrations (10, 40, 80, 160, and
320 μM) of gold(III) chloride hydrate and gallium(III) nitrate
hydrate solutions were mixed with ctDNA solutions, and
these mixtures were incubated for 2 h. After the incubation
period, absorbance spectra of the samples were read by a
NanoDrop 2000 spectrophotometer (Thermo Scientific,
USA). The wavelength range was 220–420 nm.
EB Displacement Assay
Equal concentrations of ctDNA solutions (10 mg/ml) were
mixed with ethidium bromide at a final ratio of 10:1 (DNA/
EB) in Tris-HCl buffer (pH 7.40), to obtain a DNA/EB com-
plex solution. This solution was incubated at 25 °C for 30 min
in an unilluminated room and then diluted prior tomixingwith
different concentrations of metal solutions. The final DNA
concentrations were constant for all samples (200 μM), and
the final concentrations of gold(III) chloride hydrate and
gallium(III) nitrate hydrate solutions were set at 10, 20, 50,
100, and 200 μM. Those mixtures were also incubated for
30 min in an unilluminated room and then transferred to a
microwell plate. The fluorescence values of the samples were
measured by a SpectraMaxM5Microplate Reader. Excitation
and emission wavelengths were 530 and 590 nm, respectively.
The fluorescence intensities of the samples were evaluated by
using the equation below [15]:
F ¼ I−I0ð Þ= I100−I0ð Þ ð1Þ
where F and I are the relative fluorescence and emission
intensities of EB-DNA-metal mixtures at 590 nm, respective-
ly. I0 denotes the emission intensity of free EB, and I100
denotes the emission intensity of the EB-DNA mixture.
CD Spectroscopy
For CD analysis, 200 μMctDNA and 4 mMgold(III) chloride
hydrate or gallium(III) nitrate hydrate stock solutions were
prepared. DNA concentrations were constant for all samples
(200 μM), and increasing concentrations of gold(III) chloride
hydrate and gallium(III) nitrate hydrate solutions (10, 20, 40,
100, and 200 μM at final) were obtained by diluting the main
stocks of the metal salt solutions for titration. CD spectra of
ctDNA at different metal ion concentrations were recorded
with a Jasco J-815 spectropolarimeter (Jasco, UK). For mea-
surements within 210 to 300 nm, a quartz cell with a path
length of 1 cm was utilized in nitrogen atmosphere. Three
scans of accumulation were taken for each nanometer from
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300 to 210 nm, with a scan speed of 100 nm per minute, and
sample temperature was maintained at 25 °C.
Isothermal Titration Calorimetry (ITC)
ITC experiments for calf thymus DNA-metal ion binding
were carried out at 25 °C on an iTC200 microcalorimeter
(Microcal®). Experimental setup for ITC was arranged as
follows: a total of 40 injections, a syringe concentration of
4 mM (gold(III) chloride hydrate or gallium(III) nitrate hy-
drate), a cell concentration of 200 μM (ctDNA), and a stirring
speed of 300 rpm. Injection parameters were set up using the
following parameters; volume 1 μl, duration 0.8 s, spacing
100 s,and filter period 2 s. Subtraction of pure buffer-metal
binding was performed after data acquisition. The data anal-
ysis software Origin 7.0 was used for data acquisition and
manipulation.ΔG (Gibbs free energy) calculations weremade
by the following formula [16]:
ΔG ¼ −RT ln Ka ¼ ΔH−TΔS ð2Þ
where T is the absolute temperature in Kelvin (298 K) and R=
8.3151 J mol−1 K−1.
FT-IR Spectroscopy
Solutions of ctDNA with a concentration of 200 μM and
gold(III) chloride hydrate or gallium(III) nitrate hydrate at
varying concentrations (50, 100, and 200 μM at final) were
prepared for FT-IRmeasurements and incubated for 2 h for the
establishment of metal-DNA interactions. After the incubation
period, 20 μl of final solutions were dropped and dried on a
96-well plate at 37 °C for 1 h. After drying, FT-IR transmit-
tance analysis was performed by using Nicolet 6700 FT-
Raman Spectrometer (Thermo Scientific, USA). The data
analysis software OMNICTM was used for FT-IR measure-
ments, identification of peak locations, and basic modifica-
tions such as baseline and background corrections. Back-
ground corrections for H2O and CO2 were carried out for each
analysis. Duplicate samples were utilized in each analysis, and
experiments were repeated independently for at least two
times.
Results and Discussion
UV-Vis Absorbance Spectroscopy Studies
Absorption peaks of free ctDNAwere observed at 258 nm and
displayed altered intensities in the presence of metal ions
(Fig. 1). In particular, the presence of Au(III) ions was found
to cause a gradual and concentration-dependent increase
(hyperchromism) in the absorbance spectrum, while Ga(III)
ions triggered a slight and again concentration-dependent
decrease (hypochromism). This result may suggest that
Au(III) and Ga(III) ions bind to DNA by different binding
modes and with different binding affinities. It is reported that
hypochromism is associated with charge-transfer interactions
[17] and hyperchromism is related to DNA melting and de-
naturation [18]. Therefore, the UV-Vis absorbance spectra
suggest that while Au(III) ions lead to denaturation of ctDNA
in a concentration-dependent manner, Ga(III) ions appear not
to denature it. This result may indicate that Au(III) ions show
stronger binding characteristics, since gold bears a higher
impact on the spectral intensity of DNA and has denaturing
properties that Ga(III) does not appear to display.
Competitive Binding of Au(III) and Ga(III) Ions
with EB-DNA Mixture
An ethidium bromide displacement assay was performed to
determine whether metal ions are capable of intercalative
binding to DNA and whether the intercalative binding
strengths change with the increasing metal ion concentrations.
Fig. 1 UV-Vis absorbance
spectra of ctDNAwithin 240–
280 nm, when treated with
varying molarities of a Au(III)
and b Ga(III) ions (0, 40, 80, 160,
and 320 μM)
Table 1 Relative fluorescence ratios of EB-ctDNAmixture when treated
with different concentrations of Au(III) and Ga(III) ionsa
Relative fluorescence (F) (%)





aDNA concentrations were constant for all samples (200 μM), while
metal ion concentrations were varying (50-100-200-400 μM)
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Both metal ions were found to trigger significant reductions in
the emission intensities of EB-DNA mixtures, especially at
higher concentrations (Table 1). Although, this result may
suggest that both metal ions are capable of intercalating be-
tween ctDNA strands, it is known that groove binders can also
cause a reduction in the emission intensity of EB/DNA mix-
tures, so Au(III) and Ga(III) ions may have groove-binding
properties [19]. Nevertheless, UV-Vis absorbance spectrosco-
py and EB displacement assays alone are not sufficient to fully
evaluate the binding modes, strengths, and affinities of these
metals. As such, further studies were performed to quantita-
tively determine the binding affinity differences of metal-
DNA interactions and the binding modes of metal ions to
ctDNA.
CD Spectroscopy Studies
Typically, the B-conformation of ctDNA displays a CD spec-
trum with two positive peaks at 220 and 275 nm and a
negative peak at 245 nm [20]. The peak around 245 nm
corresponds to the helicity of DNA, whereas the peak around
275 nm corresponds to the stacking of DNA bases [21], and an
intensity increase at 275 nm can be attributed to B to A
conformational change [22]. Our CD spectra suggest that
metal-DNA bindings do not significantly alter the DNA struc-
ture. As shown in Fig. 2a, interactions with Au(III) ions led to
decreases in the intensities of CD values at 245 nm and no
consistent change at 275 nm was observed, which may indi-
cate that the right-handed helicity of B-DNA is modified [21].
Since no peak shift was observed in the spectra of gold
samples and no increase in the intensity at 275 nm is present,
there is no indication for a B to A conformational transition in
DNA structure. For gallium samples, the changes at 245 and
275 nm remained minor in the CD spectra (Fig. 2b), which
may indicate that Ga(III) ions are not as influential as Au(III)
ions on ctDNA. Moreover, as with Au(III) samples, Ga(III)-
DNA interactions may take place without conformational
transitions in DNA structure. It was previously stated that
while intercalators are known to enhance the intensities of
both positive and negative bands, groove binders show less or
no perturbation on the helicity and base stacking bands [23].
Therefore, the lack of distinct signatures for conformational
Fig. 2 a, b CD spectra within
210–300 nm region and c, d CD
differences of ctDNA at the
wavelengths of 220, 245, and
275 nm, when titrated with
varying molarities of a Au(III)
and b Ga(III) ions
Fig. 3 ITC final thermograms of
a Au(III)-ctDNA and b Ga(III)-
ctDNA bindings
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transitions in our CD results indicates that both Au(III)-DNA
and Ga(III)-DNA interactions might occur without conforma-
tional changes in DNA structure. While EB displacement
assay results may suggest that Au(III) and Ga(III) ions display
intercalative binding properties, the lack of large perturbations
and intensity enhancements in CD bands of metal-DNA com-
plexes indicates that groove binding might be more responsi-
ble for metal-DNA interactions. FT-IR spectroscopy was
performed to further clarify which binding modes are domi-
nant for metal-DNA interactions.
Thermal Analysis
According to ITC results, both Au(III)-DNA and Ga(III)-
DNA reactions were exothermic (Fig. 3, Table 2) and
Au(III)-DNA interactions were observed to be much more
Table 2 Thermodynamic param-
eters obtained by ITC analysis for
the binding of ctDNAwith
Au(III) or Ga(III) ions
Thermodynamic parameters Au(III) Ga(III)
Ka(binding affinity) M
−1 1.43×106±3×105 1.17×105±1.19×104
ΔH (enthalpy change) cal mol−1 −1.745×104±242 −7,735±1.24×103
ΔS (entropy change) cal mol−1 deg−1 −30.3 −2.74
ΔG (Gibbs free energy change) kJ mol−1 −35.12 −28.92
Fig. 4 FT-IR spectra of ctDNA in
the range of 600–1,800 cm−1,
when treated with varying
molarities of a Au(III) and b
Ga(III) ions (a:0, b:100, c:200
μM of metal ions)
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favorable than Ga(III)-DNA interactions in ambient condi-
tions. Since the reactions were conducted under constant
pressure and temperature conditions and ΔG values of
Au(III)-DNA and Ga(III)-DNA reactions were negative, both
reactions are exergonic and likely to occur spontaneously
through forward direction at ambient conditions, and
Au(III)-DNA binding seems to have a higher spontaneity over
Ga(III)-DNA binding, although the homogeneity of both re-
actions avoids the accurate prediction of reaction spontaneities
[24]. Our Ka values demonstrate that Au(III) ions bind with
ctDNAwith a much higher affinity than Ga(III) ions. Accord-
ing to ΔH and ΔS values, there are considerable differences
between Au(III)-DNA and Ga(III)-DNA bindings, such that
Au(III)-DNA binding is enthalpically more favorable but
entropically less favorable than Ga(III)-DNA binding. In ad-
dition, these values were negative in both cases, and since the
ΔG values were also negative, the reactions are enthalpy
driven in both cases, and it reveals that non-covalent interac-
tions (e.g., electrostatic, van der Waals) are dominant between
Au(III)-DNA and Ga(III)-DNA bindings [25].
In summary, according to ITC analysis, binding reactions
of Au(III)-DNA and Ga(III)-DNA are likely to be spontane-
ous at ambient conditions, Au(III)-DNA binding was ob-
served to be much more favorable and much stronger than
Ga(III)-DNA binding, and this finding is parallel with the UV-
Vis spectroscopy analysis results.
FT-IR Spectroscopy Studies
FT-IR spectroscopy was performed to determine the binding
modes of Au(III) and Ga(III) ions to ctDNA within 600–
1,800 cm−1 region (Fig. 4) and to monitor whether the B-
conformation of ctDNA is altered during Au(III) or Ga(III)
binding [26]. The marker bands were chosen for different
chemical groups: 1,715 cm−1 for guanine, 1,663 cm−1 for
thymine, 1,602 cm−1 for adenine, 1,496 cm−1 for cytosine,
1,227 cm−1 for phosphate asymmetric, 1,080 cm−1 for phos-
phate symmetric, 1,060 cm−1 for sugar phosphate, 1,038 cm−1
for carbohydrate, 967 cm−1 for backbone marker, 891 cm−1
for deoxyribose, and 818 cm−1 for B-conformation marker
[21, 27–29]. For the purposes of this manuscript, shifts up to
5 cm−1 were assumed as minor. In the free DNA spectrum, the
marker bands at 1,710–1,717 cm−1 (guanine), 1,222–
1,227 cm−1 (asymmetric PO2 stretching), and 825 cm
−1 (B-
conformation marker) are signatures of the B-DNA confor-
mation [27]. For both gold and gallium samples (Table 3),
minor spectral shifts were observed for these B-conformation
markers. Minor spectral shifts were observed for nucleotide
base markers as well (guanine, thymine, adenine, and cyto-
sine), which may indicate that the metal-DNA bindings occur
via non-intercalative interactions. No major shifts occurred in
phosphate-associated bands, and the marker bands exhibited
no major shifts in the spectra of metal-DNA complexes, so the
Table 3 Peak positions and
spectral shifts of the Au(III)-
ctDNA and Ga(III)-ctDNA com-
plexes at different molar ratios
DNA bands Free ctDNA DNA—100 μM Au(III) DNA—200 μM Au(III)
Guanine 1,715 −1 −1
Thymine 1,663 0 −1
Adenine 1,602 0 0
Cytosine 1,496 0 0
Phosphate asymmetric 1,227 0 0
Phosphate symmetric 1,080 0 0
Sugar phosphate 1,060 0 −2
Carbohydrate 1,038 0 +1
Backbone marker 967 0 0
Deoxyribose 891 0 0
B-conformation marker 822 0 +3
DNA bands Free ctDNA DNA—100 μM Ga(III) DNA—200 μM Ga(III)
Guanine 1,715 −1 −1
Thymine 1,662 0 0
Adenine 1,602 0 0
Cytosine 1,496 0 0
Phosphate asymmetric 1,227 0 0
Phosphate symmetric 1,080 0 0
Sugar phosphate 1,059 −2 0
Carbohydrate 1,037 +2 +1
Backbone marker 967 −1 0
Deoxyribose 891 0 0
B-conformation marker 824 +4 +1
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minor spectral changes might occur as a result of alterations in
the sugar-phosphate geometry. Hence, ctDNA likely remained
in B-family structure following both Au(III) and Ga(III) ions’
binding y.
In conclusion, since minor shifts were observed in nucleo-
tide base peaks and no apparent alterations occurred on the
conformation of ctDNA, both Au(III) and Ga(III) ions may
bind to DNA mainly through groove binding and non-
covalent interactions instead of intercalation.
Conclusions
In this paper, the binding properties of Au(III)-DNA and
Ga(III)-DNAwere investigated by a variety of physicochem-
ical characterization tools. While EB displacement assay re-
sults demonstrated that an intercalative type of binding might
be possible between both metal ions and ctDNA, the other
analysis results indicate that groove binding and non-covalent
interactions are more meaningful for Au(III)-DNA and
Ga(III)-DNA interactions. Our results overall suggest that
the B-family structure of ctDNA is preserved during both
metal ions’ binding. Finally, thermal analysis of metal-DNA
interactions revealed that both reactions were exothermic at
ambient conditions, and Au(III)-DNA binding is more favor-
able and has a higher affinity than Ga(III)-DNA binding.
While the in vitro characterizations of Au(III)-DNA and
Ga(III)-DNA interactions detailed in this manuscript are im-
portant to elucidate the DNA-binding potential of Au(III) and
Ga(III) ions, cellular uptake and intracellular localization/
activity of these metals should also be studied to determine
their ability to access the nucleus and genomic DNA.
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